Lymphangioleiomyomatosis Clinical Trials in Charleston, South Carolina
2 recruitingCharleston, South Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 1
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
LymphangioleiomyomatosisLymphangioleiomyomatosis (LAM)
Columbia University20 enrolled2 locationsNCT06889168
Recruiting
Safety and Durability of Sirolimus for Treatment of LAM
Lymphangioleiomyomatosis
University of Cincinnati600 enrolled20 locationsNCT02432560